Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP502647.RAwVv9uum8sFDZ-0llT74mlY3yXFs4Wr8kJw9MQM2DaVk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP502647.RAwVv9uum8sFDZ-0llT74mlY3yXFs4Wr8kJw9MQM2DaVk130_assertion type Assertion NP502647.RAwVv9uum8sFDZ-0llT74mlY3yXFs4Wr8kJw9MQM2DaVk130_head.
- NP502647.RAwVv9uum8sFDZ-0llT74mlY3yXFs4Wr8kJw9MQM2DaVk130_assertion description "[Furthermore, these results suggest that targeting Cxcr2 may represent a novel therapeutic strategy for breast cancers that are associated with high levels of infiltrating macrophages.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502647.RAwVv9uum8sFDZ-0llT74mlY3yXFs4Wr8kJw9MQM2DaVk130_provenance.
- NP502647.RAwVv9uum8sFDZ-0llT74mlY3yXFs4Wr8kJw9MQM2DaVk130_assertion evidence source_evidence_literature NP502647.RAwVv9uum8sFDZ-0llT74mlY3yXFs4Wr8kJw9MQM2DaVk130_provenance.
- NP502647.RAwVv9uum8sFDZ-0llT74mlY3yXFs4Wr8kJw9MQM2DaVk130_assertion SIO_000772 22893608 NP502647.RAwVv9uum8sFDZ-0llT74mlY3yXFs4Wr8kJw9MQM2DaVk130_provenance.
- NP502647.RAwVv9uum8sFDZ-0llT74mlY3yXFs4Wr8kJw9MQM2DaVk130_assertion wasDerivedFrom befree-20150227 NP502647.RAwVv9uum8sFDZ-0llT74mlY3yXFs4Wr8kJw9MQM2DaVk130_provenance.
- NP502647.RAwVv9uum8sFDZ-0llT74mlY3yXFs4Wr8kJw9MQM2DaVk130_assertion wasGeneratedBy ECO_0000203 NP502647.RAwVv9uum8sFDZ-0llT74mlY3yXFs4Wr8kJw9MQM2DaVk130_provenance.